2,728
Views
15
CrossRef citations to date
0
Altmetric
Clinical Study

Incidence and risk factors of acute kidney injury in COVID-19 patients with and without acute respiratory distress syndrome (ARDS) during the first wave of COVID-19: a systematic review and Meta-Analysis

ORCID Icon, ORCID Icon, , , &
Pages 1621-1633 | Received 22 Jul 2021, Accepted 15 Nov 2021, Published online: 09 Dec 2021

References

  • Xu J, Yang X, Yang L, et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020;24(1):1–11.
  • Alvarez-Belon L, Sarnowski A, Forni LG. COVID-19 infection and the kidney. Br J Hosp Med. 2020;81(10):1–8.
  • Baj J, Karakuła-Juchnowicz H, Teresiński G, et al. COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. JCM. 2020;9(6):1753.
  • Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574–1581.
  • Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):303–308.
  • Gabarre P, Dumas G, Dupont T, et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1310–1339.
  • Guan W-J, Ni Z-y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
  • Darmon M, Schortgen F, Leon R, et al. Impact of mild hypoxemia on renal function and renal resistive index during mechanical ventilation. Intensive Care Med. 2009;35(6):1031–1038.
  • Izzedine H, Jhaveri KD. Acute kidney injury in patients with COVID-19: an update on the pathophysiology. Nephrol Dialysis Transplantation. 2021;36(2):224–226.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
  • Nyaga VN, Arbyn M, Aerts M. Metaprop: a stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72(1):39.
  • Yu Y, Xu D, Fu S, et al. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study. Crit Care. 2020;24(1):1–10.
  • Gasparini M, Khan S, Patel JM, et al. Renal impairment and its impact on clinical outcomes in patients who are critically ill with COVID-19: a multicentre observational study. Anaesthesia. 2021;76(3):320–326.
  • Aggarwal S, Garcia-Telles N, Aggarwal G, et al. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States. Diagnosis. 2020;7(2):91–96.
  • Chen J, Bai H, Liu J, et al. Distinct clinical characteristics and risk factors for mortality in female COVID-19 inpatients: a sex-stratified large-scale cohort study in Wuhan, China. Clin Infect Dis. 2020;71(12):3188–3195.
  • Chen L, Liu S, Tian J, et al. Disease progression patterns and risk factors associated with mortality in deceased patients with COVID-19 in Hubei province. Immun Inflamm Dis. 2020;8(4):584–594.
  • Cheng Y, Luo R, Wang X, et al. The incidence, risk factors, and prognosis of acute kidney injury in adult patients with coronavirus disease 2019. Clin J Am Soc Nephrol. 2020;15(10):1394–1402.
  • Cui X, Yu X, Wu X, et al. Acute kidney injury in patients with the coronavirus disease 2019: a multicenter study. Kidney Blood Press Res. 2020;45(4):612–622.
  • El Aidaoui K, Haoudar A, Khalis M, et al. Predictors of severity in covid-19 patients in Casablanca, Morocco. Cureus. 2020;12(9):e10716.
  • Fisher M, Neugarten J, Bellin E, et al. AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol. 2020;31(9):2145–2157.
  • Fominskiy EV, Roglio AM, Monti G, et al. Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID-19 patients with acute kidney injury and renal replacement therapy. Blood Purif. 2021;50(1):102–109.
  • Grimaldi D, Aissaoui N, Blonz G, et al. Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study. Ann Intensive Care. 2020;10(1):1–11.
  • Hong KS, Lee KH, Chung JH, et al. Clinical features and outcomes of 98 patients hospitalized with sars-cov-2 infection in Daegu, South Korea: a brief descriptive study. Yonsei Med J. 2020;61(5):431–437.
  • Okoh AK, Sossou C, Dangayach NS, et al. Coronavirus disease 19 in minority populations of Newark, New Jersey. Int J Equity Health. 2020;19(1):1–8.
  • Qian SZ, Hong WD, Lingjie M, et al. Clinical characteristics and outcomes of severe and critical patients with 2019 novel coronavirus disease (COVID-19) in Wenzhou: a retrospective study. Front Med. 2020;7:552002.
  • Russo E, Esposito P, Taramasso L, et al. Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy. J Nephrol. 2021;34(1):173–183.
  • Zahid U, Ramach R. P, Spitalewitz S, et al. Acute kidney injury in COVID-19 patients: an inner city hospital experience and policy implications. Am J Nephrol. 2020;51(10):786–796.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
  • Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612–1614.
  • Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369:m1996.
  • Ch S, Kapoor S, Orsi D, et al. COVID-19-associated critical illness-report of the first 300 patients admitted to intensive care units at a New York City medical center. J Intensive Care Med. 2020;35(10):963–970.
  • Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838.
  • Hirsch JS, Ross DW, Sharma P, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218.
  • Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020;31(6):1157–1165.
  • Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052.
  • Suleyman G, Fadel RA, Malette KM, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open. 2020;3(6):e2012270.
  • Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481.
  • Zangrillo A, Beretta L, Roglio AM, et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Critical Care and Resuscitation: Journal of the Australasian Academy of Critical Care Medicine. 2020;22(3):200–211.
  • Zheng Y, Sun L-J, Xu M, et al. Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China. J Zhejiang Univ Sci B. 2020;21(5):378–387.
  • Zhou S, Yang Y, Zhang X, et al. Clinical course of 195 critically ill COVID-19 patients: a retrospective multicenter study. Shock. 2020;54(5):644–651.
  • Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2012;2(1):1–138.
  • Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533.
  • Cooke CR, Kahn JM, Caldwell E, et al. Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Critical Care Medicine. 2008;36(5):1412–1420.
  • Darmon M, Clec’h C, Adrie C, et al. Acute respiratory distress syndrome and risk of AKI among critically ill patients. CJASN. 2014;9(8):1347–1353.
  • Panitchote A, Mehkri O, Hastings A, et al. Factors associated with acute kidney injury in acute respiratory distress syndrome. Ann Intensive Care. 2019;9(1):74.
  • Ahmed AR, Ebad CA, Stoneman S, et al. Kidney injury in COVID-19. World J Nephrol. 2020;9(2):18–32.
  • Chaibi K, Dao M, Pham T, et al. Severe acute kidney injury in patients with COVID-19 and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;202(9):1299–1301.
  • Portolés J, Marques M, López-Sánchez P, de Valdenebro M, et al. Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak. Nephrol Dial Transplant. 2020;35(8):1353–1361.
  • Nadim MK, Forni LG, Mehta RL, et al. COVID-19-associated acute kidney injury: consensus report of the 25th acute disease quality initiative (ADQI) workgroup. Nat Rev Nephrol. 2020;16(12):747–764.
  • Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome. J Am Soc Nephrol. 2006;17(4 Suppl 2):S81–S5.
  • Lohia P, Kapur S, Benjaram S, et al. Metabolic syndrome and clinical outcomes in patients infected with COVID-19: does age, sex, and race of the patient with metabolic syndrome matter? J Diabetes. 2021;13(5):420–429.
  • Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140(3):167–174.
  • Ali H, Daoud A, Mohamed MM, et al. Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis. Ren Fail. 2020;42(1):393–397.